 SAN MATEO, Calif. and SINGAPORE, Dec. 16, 2022 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals Nasdaq: ASLN, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the Companys participation in upcoming conferences for January 2023. Listed below are meetings that management will be attending around the week of the J.P. Morgan 41st Annual Healthcare Conference. 